269 related articles for article (PubMed ID: 27232927)
1. The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinion.
Nieminen MS; Buerke M; Cohen-Solál A; Costa S; Édes I; Erlikh A; Franco F; Gibson C; Gorjup V; Guarracino F; Gustafsson F; Harjola VP; Husebye T; Karason K; Katsytadze I; Kaul S; Kivikko M; Marenzi G; Masip J; Matskeplishvili S; Mebazaa A; Møller JE; Nessler J; Nessler B; Ntalianis A; Oliva F; Pichler-Cetin E; Põder P; Recio-Mayoral A; Rex S; Rokyta R; Strasser RH; Zima E; Pollesello P
Int J Cardiol; 2016 Sep; 218():150-157. PubMed ID: 27232927
[TBL] [Abstract][Full Text] [Related]
2. Effects of Levosimendan on Patients with Heart Failure Complicating Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials.
Shang G; Yang X; Song D; Ti Y; Shang Y; Wang Z; Tang M; Zhang Y; Zhang W; Zhong M
Am J Cardiovasc Drugs; 2017 Dec; 17(6):453-463. PubMed ID: 28597399
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic treatment of heart failure due to ventricular dysfunction by myocardial stunning: potential role of levosimendan.
García González MJ; Domínguez Rodríguez A
Am J Cardiovasc Drugs; 2006; 6(2):69-75. PubMed ID: 16555860
[TBL] [Abstract][Full Text] [Related]
4. Levosimendan in the treatment of cardiogenic shock.
Buerkem B; Lemm H; Krohe K; Dietz S; Raaz U; Buerke U; Russ M; Schlitt A; Werdan K
Minerva Cardioangiol; 2010 Aug; 58(4):519-30. PubMed ID: 20938415
[TBL] [Abstract][Full Text] [Related]
5. Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paper.
Farmakis D; Alvarez J; Gal TB; Brito D; Fedele F; Fonseca C; Gordon AC; Gotsman I; Grossini E; Guarracino F; Harjola VP; Hellman Y; Heunks L; Ivancan V; Karavidas A; Kivikko M; Lomivorotov V; Longrois D; Masip J; Metra M; Morelli A; Nikolaou M; Papp Z; Parkhomenko A; Poelzl G; Pollesello P; Ravn HB; Rex S; Riha H; Ricksten SE; Schwinger RHG; Vrtovec B; Yilmaz MB; Zielinska M; Parissis J
Int J Cardiol; 2016 Nov; 222():303-312. PubMed ID: 27498374
[TBL] [Abstract][Full Text] [Related]
6. Levosimendan: a retrospective single-center case series.
Berry WT; Hewson RW; Langrish CJ; McKenzie CA; Barrett NA
J Crit Care; 2013 Dec; 28(6):1075-8. PubMed ID: 23998721
[TBL] [Abstract][Full Text] [Related]
7. The utility of levosimendan in the treatment of heart failure.
Lehtonen L; Põder P
Ann Med; 2007; 39(1):2-17. PubMed ID: 17364447
[TBL] [Abstract][Full Text] [Related]
8. Levosimendan: A promising agent for the treatment of hospitalized patients with decompensated heart failure.
Lehtonen L
Curr Cardiol Rep; 2000 May; 2(3):233-43. PubMed ID: 10980898
[TBL] [Abstract][Full Text] [Related]
9. Levosimendan: current status and future prospects.
Archan S; Toller W
Curr Opin Anaesthesiol; 2008 Feb; 21(1):78-84. PubMed ID: 18195615
[TBL] [Abstract][Full Text] [Related]
10. Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study.
Husebye T; Eritsland J; Müller C; Sandvik L; Arnesen H; Seljeflot I; Mangschau A; Bjørnerheim R; Andersen GØ
Eur J Heart Fail; 2013 May; 15(5):565-72. PubMed ID: 23288914
[TBL] [Abstract][Full Text] [Related]
11. The clinical experience with levosimendan in anesthesiology and in the intensive care unit.
Cavana M; Pignataro C; Fraticelli A; Mebazaa A
Ital Heart J; 2003 May; 4 Suppl 2():61S-64S. PubMed ID: 14635372
[TBL] [Abstract][Full Text] [Related]
12. Levosimendan: a calcium-sensitizing agent for the treatment of patients with decompensated heart failure.
Lehtonen L
Curr Heart Fail Rep; 2004 Sep; 1(3):136-44. PubMed ID: 16036037
[TBL] [Abstract][Full Text] [Related]
13. Use of levosimendan, a new inodilator, for postoperative myocardial stunning in a premature neonate.
Lechner E; Moosbauer W; Pinter M; Mair R; Tulzer G
Pediatr Crit Care Med; 2007 Jan; 8(1):61-3. PubMed ID: 17149153
[TBL] [Abstract][Full Text] [Related]
14. European experience on the practical use of levosimendan in patients with acute heart failure syndromes.
Follath F; Franco F; Cardoso JS
Am J Cardiol; 2005 Sep; 96(6A):80G-5G. PubMed ID: 16181827
[TBL] [Abstract][Full Text] [Related]
15. Management of acute cardiac failure by intracoronary administration of levosimendan.
Caimmi PP; Kapetanakis EI; Beggino C; Molinari C; Giustini G; Crosio E; Reposo G; Micalizzi E; Vacca G; Grossini E
J Cardiovasc Pharmacol; 2011 Sep; 58(3):246-53. PubMed ID: 21654504
[TBL] [Abstract][Full Text] [Related]
16. Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction.
Fuhrmann JT; Schmeisser A; Schulze MR; Wunderlich C; Schoen SP; Rauwolf T; Weinbrenner C; Strasser RH
Crit Care Med; 2008 Aug; 36(8):2257-66. PubMed ID: 18664782
[TBL] [Abstract][Full Text] [Related]
17. Levosimendan for the treatment of acute heart failure syndromes.
Parissis JT; Filippatos G; Farmakis D; Adamopoulos S; Paraskevaidis I; Kremastinos D
Expert Opin Pharmacother; 2005 Dec; 6(15):2741-51. PubMed ID: 16316312
[TBL] [Abstract][Full Text] [Related]
18. Levosimendan: a novel inotropic agent for treatment of acute, decompensated heart failure.
Earl GL; Fitzpatrick JT
Ann Pharmacother; 2005 Nov; 39(11):1888-96. PubMed ID: 16219899
[TBL] [Abstract][Full Text] [Related]
19. [Inotrope therapy in acute heart failure: a critical review of clinical and scientific evidence for levosimendan in the context of traditional treatment].
Ambrosio G; Di Lenarda A; Fedele F; Gabrielli D; Metra M; Oliva F; Perna G; Senni M; De Maria R
G Ital Cardiol (Rome); 2009 Jul; 10(7):422-33. PubMed ID: 19761100
[TBL] [Abstract][Full Text] [Related]
20. A review of levosimendan in the treatment of heart failure.
Kasikcioglu HA; Cam N
Vasc Health Risk Manag; 2006; 2(4):389-400. PubMed ID: 17323593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
